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Central Retinal Vein Occlusion Secondary to Ocular Trauma  
in a Young Patient: A Case Report
Abstract
Central retinal vein occlusions (CRVO) occurring in young patients or due 
to a traumatic etiology are uncommon. This paper outlines the case of a 
33-year-old Asian male who presented with a chief complaint of blurry pe-
ripheral vision and photophobia in his left eye, one week after sustaining 
blunt ocular trauma. He was diagnosed with a traumatic CRVO based on 




After diabetic retinopathy, retinal vein occlusions are the second-most 
common cause of retinal vascular disorders. Branch retinal vein occlusions 
are more common, with a prevalence in the US population of 0.5% to 1.2%, 
compared to CRVOs, which occur at a prevalence of 0.1% to 0.5%.1 CRVO 
typically presents as sudden-onset, unilateral painless vision loss in vascu-
lopathic individuals who are 50 years of age or older. CRVO is rare in indi-
viduals 40 years old or younger, and for these individuals etiologies such 
as oral contraceptive use, collagen vascular disease, acquired immune defi-
ciency syndrome (AIDS), protein S/protein C deficiency, anti-thrombin III 
deficiency, factor XII deficiency, antiphospholipid antibody syndrome or 
activated protein C resistance should be considered.2 In rare cases, a CRVO 
can be a clinical manifestation of ocular trauma. 
CASE REPORT
History
A 33-year-old Asian male presented with a chief complaint of blurry pe-
ripheral vision and photophobia in his left eye for one week. He reported 
a recent history of trauma that occurred two weeks prior; he was hit in the 
left eye during Jiu Jitsu practice. The peripheral visual blur and photopho-
bia occurred one week after the injury. The patient’s ocular history revealed 
compound myopic astigmatism with a history of laser-assisted in situ ker-
atomileusis (LASIK). The patient’s medical history was unremarkable and 
he was not taking any medications. He had no known allergies. 
Clinical Exam
The patient’s best corrected visual acuity (BCVA) was 20/20 OD, OS. His pu-
pils were equal in size, round, and reactive to light with no afferent pupillary 
defect (APD). Extraocular motilities were unrestricted and he demonstrated 
full confrontation visual fields OU. The slit lamp examination of the anterior 
segment was unremarkable except for trace cells OS. No ecchymosis, edema 
or abnormal ocular adnexa findings were noted OU. His intraocular pres-
sures (IOP) measured by Goldmann tonometry were 10 mmHg OD and 11 
mmHg OS. Upon dilated fundus examination (DFE), the right eye was unre-
markable and the left eye was significant for optic disc edema with peripapil-
lary hemorrhages, diffuse parafoveal flame hemorrhages in the macula and 
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the retina (Figures 1, 2). This was an atypical presentation of CRVO as hemorrhaging in this case was concentrated 
around the disc, with less severe bleeding away from the posterior pole. This may have been due to significant pressure 
on the optic nerve itself due to trauma, as opposed to the vasculopathic etiology of other CRVOs. Optical coherence 
tomography (OCT) of the macula demonstrated a flat and intact macula with no subretinal or intraretinal fluid OU 
(Figure 3). OCT of the retinal nerve fiber layer was within normal limits OD and was elevated 360 degrees OS, confirm-
ing peri-papillary edema (Figure 4). The patient’s in-office blood pressure was 123/73 mmHg. 
Figures 1 and 2: Right and left posterior poles with extensive hemorrhages OS
Figure 3: Macular OCTs with mild increased macular thickening OS 
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Figure 4: OCTs of the optic nerve heads with optic nerve swelling OS 
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Diagnosis and Treatment
Given the recent history of trauma and the exam findings, the patient was diagnosed with a traumatic CRVO with a 
mild traumatic iritis OS. The case was reviewed with a retinal specialist who agreed on the diagnosis and etiology, 
pending lab results to rule out systemic blood dyscrasia. The patient was educated on the condition’s self-resolving 
nature and was advised to avoid strenuous activities. He was prescribed prednisolone acetate three times a day os for 
the iritis and was scheduled to return in two weeks for an IOP check, gonioscopy, DFE, OCT Macula and OCT RNFL. 
Follow-Up and Additional Testing
The patient was followed up two weeks after his initial exam, at which time resolution of the anterior chamber reac-
tion was observed. The topical steroid was therefore tapered and the patient was monitored at monthly intervals for 
the development of neovascularization or worsening of clinical signs or symptoms. Over the course of his monthly 
follow-up visits, the patient’s BCVA remained 20/20 OD, OS and he subjectively reported improvement and resolu-
tion in symptoms of peripheral blur OS. Gonioscopy was performed at all follow-up visits and no angle recession or 
neovascularization was noted. The patient demonstrated gradual resolution of the fundus findings and optic disc 
swelling at every follow-up, with significant improvement five months after the initial presentation (Figures 5, 6). 
Additional laboratory testing ruled out other etiologies that could account for CRVO in a young patient (Table 1). 
Figure 5: Left posterior pole with resolution of retinal hemorrhages 
DISCUSSION
In the United States, traumatic ocular injuries are responsible for approximately 30,000 visits to the emergency de-
partment annually.3 Common traumatic ocular findings include contusion, ecchymosis, hyphema, cataract, glauco-
ma, vitreous hemorrhage, retinal hemorrhage and commotio retinae. Trauma-related CRVO highlighted in this case 
report is a very rare manifestation of ocular trauma and only a few examples have been described in the literature. 
Clinical signs of CRVO include superficial and deep retinal hemorrhages in all four retinal quadrants, vessel en-
gorgement and tortuosity, optic disc swelling, cotton wool spots, and cystoid macular edema.1 CRVOs typically occur 
in individuals over the age of 50 with risk factors that include hypertension, vascular disease, and African-American 
racial background. In addition, patients with end-organ damage due to diabetes mellitus are at an increased risk of 
CRVO compared to patients with uncomplicated diabetes mellitus.4 Other less common causes include oral contra-
ceptive pills, collagen vascular disease, AIDS, protein S deficiency, protein C deficiency, antithrombin III deficiency, 
factor XII deficiency, antiphospholipid antibody syndrome and activated protein C resistance. 
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Figure 6: OCT of left optic nerve head with resolution of optic nerve swelling 
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Table 1: Lab tests indicating no underlying etiologies to account for a CRVO in a young patient. 
Test Result Reference Range
ESR 4 mm/h 0-22 mm/h
Homocysteine 9.8 μmol/L 0.0-15.0 μmol/L 
ANA Positive* <1:40 
RPR Non-reactive Non-reactive 
MHA-TP Non-reactive Non-reactive 
LDL Cholesterol 145.2 mg/dL 0-130 mg/dL 
Total Cholesterol 225 mg/dL 0-200 mg/dL 
HDL 59 mg/dL 29-72 mg/dL 
Triglyceride 102 mg/dL 10-170 mg/dL 
WBC 5.2 103/μL 3.5-10.0 103/μL
RBC 5.4 106/μL 4.0-5.9 106/μL
Hemoglobin 15.2 g/dL 12.0-18.0 g/dL 
HCT 46.0% 36.0-52% 
MCV 85.9 fL 81-100 fL 
MCH 28.3 pg 27-35 pg 
MCHC 33.0 g/dL 33.0-36.0 g/dL 
RDW 13.0% 12.3-16.4%
Platelet Count 222 103/μL 150-450 103/μL
MPV 9.1 fL 7.4-10.4 fL 
Neutrophil % 61.5% 45.0-75.0%
Lymphocyte % 28.0% 18.0-43.0%
Monocyte % 7.3% 2.0-14.0%
Eosinophil % 2.6% 0.0-8.0%
Basophil % 0.6% 0.0-2.0%
Neutrophil (#) 3.20 103/μL 1.6-7.5 103/μL
Lymph (#) 1.50 103/μL 0.6-4.3 103/μL
Mono (#) 0.40 103/μL 0.1-1.4 103/μL
Eos (#) 0.10 103/μL 0.0-0.8 103/μL
Baso (#) 0.00 103/μL 0.0-0.2 103/μL
PTime 13.1 seconds 12.0-14.7 seconds 
PTT 33.4 seconds 23.6-36.6 seconds 
Anticardiolipin AB, IgG < 9 GPL U/mL 0-14 GPL U/mL 
Anticardiolipin AB, IgM < 9 MPL U/mL 0-12 MPL U/mL 
* Positive ANA at a concentration of 1:40, at which some subjects in the normal population test positive without systemic 
issues. ANA was not found to be positive at more dilute concentrations.
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CRVO is sub-divided into non-ischemic and ischemic. An ischemic CRVO is defined as capillary non-perfusion on 
fluorescein angiogram (FA) of more than 10 disc diameters.2 In patients with ischemic CRVO, elevated levels of 
protein related to hypoxia, angiogenesis and inflammation make development of neovascularization more likely.5 
The visual prognosis in CRVO can vary from 20/20 to hand motion. Vision loss due to extensive hemorrhaging at 
initial presentation can improve as the hemorrhages resolve, or vision can conversely worsen due to prolonged reti-
nal non-perfusion. Non-perfusion can subsequently cause the increased production of vascular endothelial growth 
factor (VEGF), which may lead to macular edema and neovascularization.5 Our patient’s CRVO was diagnosed as 
non-ischemic due to the lack of severe vision loss and the absence of a relative afferent pupillary defect (RAPD). A 
FA was not ordered due to the low degree of suspicion of ischemic etiology in this case. 
Trauma-related CRVOs are rare in the literature. According to Hayreh et al., 10 out of 680 individuals had a CRVO after 
blunt trauma.6 El Asri et al. reported the case of a 35-year-old male who sustained ocular trauma due to a blast injury in a 
conflict zone and presented with a sudden decline in vision due to a CRVO.7 This case differs from our patient’s case since 
this patient experienced decreased vision and further analysis showed a positive factor II G20210A gene mutation. Our 
patient has not yet had genetic testing, and it is possible that he may have a gene mutation that predisposes him to the oc-
currence of CRVO. Alvarez and Noble reported a case of a combined central retinal artery occlusion (CRAO) and CRVO in 
a 28-year-old who was jabbed in the eye as opposed to the CRVO without arterial occlusion that occurred in our patient.8 
In a typical case of CRVO, the pathogenesis is thought to involve obstruction of the central retinal venous outflow. 
Different factors such as vascular changes, hematologic and thrombotic tendencies, and local anatomical suscep-
tibility can also contribute to the development of a CRVO.1 Our patient sustained blunt trauma to the eye during 
Jiu Jitsu, resulting in acute mechanical deformation of the eye and subsequent collapse of the central retinal vein 
against the lamina cribrosa. Alternatively, increased IOP can create a greater pressure-difference as the vein exits 
the eye. However, this etiology was ruled out because our patient had normal, symmetric IOPs, absence of a hy-
phema and no angle recession on gonioscopy. Finally, congenital anomalies, such as increased vascular tortuosity 
or anomalous anatomic configuration, may affect the hemodynamics of venous outflow and predispose the central 
retinal vein to thrombosis.9 Our patient had an acute CRVO with likely gradual development of optic nerve head 
edema. This may be why his symptoms of peripheral visual blur were not acute and presented after one week.
The natural course of a traumatic CRVO in young adults is spontaneous resolution over three to six months, with 
a minimal decrease in best corrected visual acuity. Fong and Schatz reviewed 488 cases and reported that these 
patients typically recover in an average of 12.2 weeks.10 With regard to treatment, the Study of Comparative Treat-
ments for Retinal Vein Occlusion 2 (SCORE2) established that all three anti-VEGF agents (aflibercept, bevacizumab 
and ranibizumab) are effective in the treatment of macular edema.11 The prognosis of CRVO usually depends on 
whether it is non-ischemic or ischemic. Non-ischemic CRVO typically has a better final visual outcome. 
CONCLUSION
Though CRVOs typically occur in the vasculopathic population aged 50 years and older, this case report describes 
the unusual sequelae of a CRVO in a young patient following blunt trauma. As eye care providers, it is important 
that we are aware of common complications as well as more rare manifestations of ocular trauma. A thorough case 
history and appropriate, prompt management should help to prevent further ocular complications. l
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